Access cutting-edge schizophrenia treatment through this clinical trial at a research site in Little Rock. Study-provided care at no cost to qualified participants.
Access schizophrenia specialists in Little Rock at no cost
This study follows strict safety protocols and ethical guidelines
All study-related schizophrenia treatment provided free
This is a Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Determine the the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants with Schizophrenia
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Check if you qualify for this schizophrenia clinical trial in Little Rock, AR
If you're searching for schizophrenia treatment options in Little Rock, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Little Rock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced schizophrenia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.